# Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

> **NCT00667563** · PHASE1 · COMPLETED · sponsor: **AIDS Malignancy Consortium** · enrollment: 150 (actual)

## Conditions studied

- Cervical Cancer
- Nonneoplastic Condition
- Precancerous Condition

## Interventions

- **BIOLOGICAL:** quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
- **GENETIC:** DNA analysis
- **GENETIC:** polymerase chain reaction
- **OTHER:** cytology specimen collection procedure
- **PROCEDURE:** colposcopic biopsy

## Key facts

- **NCT ID:** NCT00667563
- **Lead sponsor:** AIDS Malignancy Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667563, "Vaccine Therapy in Preventing HPV in HIV-Positive Women in India". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00667563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*